5 Results for "

HER2-IN-9

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "HER2-IN-9" in MCE Product Catalog:

Cat. No.: HY-143323
Target:  

EGFR

Research Areas:  

Cancer

HER2-IN-9 is an orally active HER2 inhibitor, with an IC50 value of 0.03 μM. HER2-IN-9 inhibits HER-2 positive breast cancer cells proliferation and migration. HER2-IN-9 can be used in the research of breast cancers .
loading...
    loading...
Cat. No.: HY-153111
CAS No.: 1637253-79-2
Purity:  98.73%
Target:  

EGFR

Research Areas:  

Cancer

EGFR/HER2-IN-9 (Compound 1) is an EGFR and HER2 inhibitor with IC50s of 3.2, 8.3 and 14 nM against EGFR, EGFR T790M and HER2, respectively .
loading...
    loading...
Cat. No.: HY-147796
CAS No.: 879730-44-6
Target:  

EGFR CDK

Research Areas:  

Cancer

EGFR/HER2/CDK9-IN-1 (Compound 4) is a potent inhibitor of EGFR/HER2/CDK9 with IC50s of 90.17, 131.39, and 67.04 nM, respectively. EGFR/HER2/CDK9-IN-1 exhibits remarkable antitumor activity .
loading...
    loading...
Cat. No.: HY-147797
CAS No.: 1180924-34-8
Target:  

EGFR CDK

Research Areas:  

Cancer

EGFR/HER2/CDK9-IN-2 (Compound 9) is a potent inhibitor of EGFR/HER2/CDK9 with IC50s of 145.35, 129.07, and 117.13 nM, respectively. EGFR/HER2/CDK9-IN-2 exhibits remarkable antitumor activity .
loading...
    loading...
Cat. No.: HY-147798
CAS No.: 422276-47-9
Target:  

EGFR CDK

Research Areas:  

Cancer

EGFR/HER2/CDK9-IN-3 (Compound 10) is a potent inhibitor of EGFR/HER2/CDK9 with IC50s of 191.08, 132.65, and 113.98 nM, respectively. EGFR/HER2/CDK9-IN-3 exhibits remarkable antitumor activity .
loading...
    loading...